Macrophage Reprogramming with Anti‐miR223‐Loaded Artificial Protocells Enhances In Vivo Cancer Therapeutic Potential (Adv. Sci. 35/2022)

Macrophage Reprogramming In article number 2202717, Stephen Mann, Paul Martin, and co‐workers used a zebrafish model of melanoma, which develops human‐like tumors mainly in the tail, to test a novel cancer immunotherapy approach based on the intravenous or direct injection of miniature artificial pr...

Descripción completa

Detalles Bibliográficos
Autores principales: López‐Cuevas, Paco, Xu, Can, Severn, Charlotte E., Oates, Tiah C. L., Cross, Stephen J., Toye, Ashley M., Mann, Stephen, Martin, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Back Cover
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762276/
http://dx.doi.org/10.1002/advs.202270226
Descripción
Sumario:Macrophage Reprogramming In article number 2202717, Stephen Mann, Paul Martin, and co‐workers used a zebrafish model of melanoma, which develops human‐like tumors mainly in the tail, to test a novel cancer immunotherapy approach based on the intravenous or direct injection of miniature artificial protocells that can circulate in blood and deliver reprogramming cargoes to immune cells to enhance their anti‐cancer potential. [Image: see text]

Ejemplares similares